In 2024, French pharmaceutical company Sanofi generated approximately 41 billion euros through its biopharmaceutical segment. In 2023, Sanofi’s consumer healthcare segment earned the company about 5.2 billion euros in that year. As of early 2025, due to several restructuring measures, Sanofi consists only of the biopharma segment.
Sanofi’s top products
Sanofi develops various pharmaceutical products, including Dupixent and Lantus. Lantus has been one of the company’s top products for many years. In 2024, this long-acting insulin, used to treat diabetes, generated some 1.6 billion euros.
Top U.S. drugs
Based on sales numbers over the last years, Humira is by far the top prescription drug in the United States. Before 2023, the drug generated around 20 billion U.S. dollars in the United States per year. Among the country’s most prescribed medicines, however, are atorvastatin, lisinopril, and levothyroxine.
Revenue of Sanofi by segment from 2014 to 2024
(in million euros)
* From 2023 on, called "Biopharma" ("Pharmaceuticals" + "Vaccines").
** During 2016, the Animal Health and the Consumer Healthcare segments were the objects of a swap deal between Sanofi and Boehringer Ingelheim. Since 2016, Animal Health revenues were no longer part of Sanofi's total revenues
*** For 2024, the ongoing separation process of the consumer healthcare segment (Opella) is already classified as discontinued operation, and thus not included.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sanofi, & Company filings. (February 17, 2025). Revenue of Sanofi by segment from 2014 to 2024 (in million euros) [Graph]. In Statista. Retrieved May 17, 2025, from https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi, und Company filings. "Revenue of Sanofi by segment from 2014 to 2024 (in million euros)." Chart. February 17, 2025. Statista. Accessed May 17, 2025. https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi, Company filings. (2025). Revenue of Sanofi by segment from 2014 to 2024 (in million euros). Statista. Statista Inc.. Accessed: May 17, 2025. https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi, and Company filings. "Revenue of Sanofi by Segment from 2014 to 2024 (in Million Euros)." Statista, Statista Inc., 17 Feb 2025, https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi & Company filings, Revenue of Sanofi by segment from 2014 to 2024 (in million euros) Statista, https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/ (last visited May 17, 2025)
Revenue of Sanofi by segment from 2014 to 2024 (in million euros) [Graph], Sanofi, & Company filings, February 17, 2025. [Online]. Available: https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
